0001752724-23-190624.txt : 20230825
0001752724-23-190624.hdr.sgml : 20230825
20230825125124
ACCESSION NUMBER: 0001752724-23-190624
CONFORMED SUBMISSION TYPE: NPORT-P
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230630
FILED AS OF DATE: 20230825
DATE AS OF CHANGE: 20230825
PERIOD START: 20231231
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: MORGAN STANLEY INSTITUTIONAL FUND INC
CENTRAL INDEX KEY: 0000836487
IRS NUMBER: 000000000
STATE OF INCORPORATION: MD
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: NPORT-P
SEC ACT: 1940 Act
SEC FILE NUMBER: 811-05624
FILM NUMBER: 231205740
BUSINESS ADDRESS:
STREET 1: 522 FIFTH AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10036
BUSINESS PHONE: 800-548-7786
MAIL ADDRESS:
STREET 1: 522 FIFTH AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10036
FORMER COMPANY:
FORMER CONFORMED NAME: MORGAN STANLEY DEAN WITTER INSTITUTIONAL FUND INC
DATE OF NAME CHANGE: 19990329
FORMER COMPANY:
FORMER CONFORMED NAME: MORGAN STANLEY INSTITUTIONAL FUND INC
DATE OF NAME CHANGE: 19920703
0000836487
S000074797
Vitality Portfolio
C000233002
Class I
MSVDX
C000233003
Class A
MSVEX
C000233004
Class C
MSVMX
C000233005
Class R6
MSVOX
NPORT-P
1
primary_doc.xml
NPORT-P
false
0000836487
XXXXXXXX
S000074797
C000233003
C000233002
C000233004
C000233005
MORGAN STANLEY INSTITUTIONAL FUND INC
811-05624
0000836487
54930067DYRSUSGS4E97
522 FIFTH AVENUE
NEW YORK
10036
800-869-6397
Vitality Portfolio
S000074797
549300V9WWJX6LPH4Y61
2023-12-31
2023-06-30
N
2393566.86
26246.88
2367319.98
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
0.00000000
N
GH Research PLC
875500HKJS7QQG6EWH62
GH Research PLC
000000000
958.00000000
NS
USD
11366.67000000
0.480149286789
Long
EC
CORP
IE
N
1
N
N
N
10X Genomics Inc
5493003Z6741WNLG7H43
10X Genomics Inc
88025U109
2378.00000000
NS
USD
132787.52000000
5.609191876123
Long
EC
CORP
US
N
1
N
N
N
HSBC Securities (USA) Inc.
CYYGQCGNHMHPSMRL3R97
HSBC TRI PARTY A REPO
000000000
421.08526743
PA
USD
421.08526743
0.017787425062
Long
RA
CORP
US
N
2
Repurchase
Y
5.05000000
2023-07-03
440.19252400
USD
429.50697362
USD
UST
N
N
Alnylam Pharmaceuticals Inc
529900S3ZI14OWRJII50
Alnylam Pharmaceuticals Inc
02043Q107
419.00000000
NS
USD
79584.86000000
3.361812542130
Long
EC
CORP
US
N
1
N
N
N
Relay Therapeutics Inc
N/A
Relay Therapeutics Inc
75943R102
1230.00000000
NS
USD
15448.80000000
0.652586052182
Long
EC
CORP
US
N
1
N
N
N
Vertex Pharmaceuticals Inc
54930015RAQRRZ5ZGJ91
Vertex Pharmaceuticals Inc
92532F100
276.00000000
NS
USD
97127.16000000
4.102831928956
Long
EC
CORP
US
N
1
N
N
N
UnitedHealth Group Inc
549300GHBMY8T5GXDE41
UnitedHealth Group Inc
91324P102
232.00000000
NS
USD
111508.48000000
4.710325640051
Long
EC
CORP
US
N
1
N
N
N
Exact Sciences Corp
549300VM3X1FYD4N9Z14
Exact Sciences Corp
30063P105
1207.00000000
NS
USD
113337.30000000
4.787578399097
Long
EC
CORP
US
N
1
N
N
N
Merrill Lynch, Pierce, Fenner & Smith Incorporated
8NAV47T0Y26Q87Y0QP81
MERRILL LYNCH TRI PARTY A REPO
000000000
336.86821394
PA
USD
336.86821394
0.014229940049
Long
RA
CORP
US
N
2
Repurchase
Y
5.05000000
2023-07-03
340.11057100
USD
343.60766849
USD
UST
N
N
agilon health Inc
N/A
agilon health Inc
00857U107
2814.00000000
NS
USD
48794.76000000
2.061181437753
Long
EC
CORP
US
N
1
N
N
N
AbCellera Biologics Inc
9845000861BC95FF9F73
AbCellera Biologics Inc
00288U106
3223.00000000
NS
USD
20820.58000000
0.879500032775
Long
EC
CORP
CA
N
1
N
N
N
Thermo Fisher Scientific Inc
HCHV7422L5HDJZCRFL38
Thermo Fisher Scientific Inc
883556102
213.00000000
NS
USD
111132.75000000
4.694454105861
Long
EC
CORP
US
N
1
N
N
N
Beam Therapeutics Inc
N/A
Beam Therapeutics Inc
07373V105
1368.00000000
NS
USD
43680.24000000
1.845134598154
Long
EC
CORP
US
N
1
N
N
N
Ascendis Pharma A/S
549300B66JN3W3J8GH73
Ascendis Pharma A/S
04351P101
261.00000000
NS
USD
23294.25000000
0.983992455468
Long
EC
CORP
DK
N
1
N
N
N
Intellia Therapeutics Inc
5493002T5BCPE5DZC723
Intellia Therapeutics Inc
45826J105
1593.00000000
NS
USD
64962.54000000
2.744138542690
Long
EC
CORP
US
N
1
N
N
N
Zoetis Inc
549300HD9Q1LOC9KLJ48
Zoetis Inc
98978V103
340.00000000
NS
USD
58551.40000000
2.473320062123
Long
EC
CORP
US
N
1
N
N
N
Inspire Medical Systems Inc
549300XQQCQ7HCJKTW25
Inspire Medical Systems Inc
457730109
324.00000000
NS
USD
105183.36000000
4.443140804311
Long
EC
CORP
US
N
1
N
N
N
Align Technology Inc
549300N5YSE0U3LCP840
Align Technology Inc
016255101
210.00000000
NS
USD
74264.40000000
3.137066413810
Long
EC
CORP
US
N
1
N
N
N
Veeva Systems Inc
549300YZEXPDB92M2F02
Veeva Systems Inc
922475108
259.00000000
NS
USD
51212.07000000
2.163293109197
Long
EC
CORP
US
N
1
N
N
N
Moderna Inc
549300EI6OKH5K5Q2G38
Moderna Inc
60770K107
372.00000000
NS
USD
45198.00000000
1.909247604119
Long
EC
CORP
US
N
1
N
N
N
Morgan Stanley & Co. LLC
549300OJY9IZ31SGS926
Morgan Stanley Institutional Liquidity Funds - Treasury Securities Portfolio
61747C525
148608.04000000
NS
USD
148608.04000000
6.277480072634
Long
STIV
RF
US
N
1
N
N
N
ATAI Life Sciences NV
391200Z8UWPJSNBNCA11
ATAI Life Sciences NV
000000000
8904.00000000
NS
USD
15314.88000000
0.646929022243
Long
EC
CORP
NL
N
1
N
N
Illumina Inc
SQ95QG8SR5Q56LSNF682
Illumina Inc
452327109
289.00000000
NS
USD
54184.61000000
2.288858728763
Long
EC
CORP
US
N
1
N
N
N
Doximity Inc
N/A
Doximity Inc
26622P107
1353.00000000
NS
USD
46029.06000000
1.944353124582
Long
EC
CORP
US
N
1
N
N
N
SomaLogic Inc
549300D3W3Q8CN30YO25
SomaLogic Inc
83444K105
12320.00000000
NS
USD
28459.20000000
1.202169552085
Long
EC
CORP
US
N
1
N
N
N
Guardant Health Inc
254900M8C3E5VC8BR186
Guardant Health Inc
40131M109
892.00000000
NS
USD
31933.60000000
1.348934671687
Long
EC
CORP
US
N
1
N
N
N
Fate Therapeutics Inc
549300L14Q4UHOODLA90
Fate Therapeutics Inc
31189P102
1572.00000000
NS
USD
7482.72000000
0.316084013281
Long
EC
CORP
US
N
1
N
N
N
Intuitive Surgical Inc
54930052SRG011710797
Intuitive Surgical Inc
46120E602
306.00000000
NS
USD
104633.64000000
4.419919608839
Long
EC
CORP
US
N
1
N
N
N
Argenx SE
7245009C5FZE6G9ODQ71
Argenx SE
04016X101
245.00000000
NS
USD
95483.85000000
4.033415457423
Long
EC
CORP
NL
N
1
N
N
N
Schrodinger Inc/United States
N/A
Schrodinger Inc/United States
80810D103
1523.00000000
NS
USD
76028.16000000
3.211570917421
Long
EC
CORP
US
N
1
N
N
N
Altimmune Inc
549300EOYCQ8SW3NVE64
Altimmune Inc
02155H200
1044.00000000
NS
USD
3685.32000000
0.155674772786
Long
EC
CORP
US
N
1
N
N
N
Evotec SE
529900F9KI6OYITO9B12
Evotec SE
30050E105
3481.00000000
NS
USD
38952.39000000
1.645421418696
Long
EC
CORP
DE
N
1
N
N
N
Morgan Stanley & Co. LLC
549300OJY9IZ31SGS926
Morgan Stanley Institutional Liquidity Funds - Treasury Securities Portfolio
61747C525
11369.30222586
NS
USD
11369.30222586
0.480260476906
Long
STIV
RF
US
N
1
N
N
Chewy Inc
254900NPQSTG9I422879
Chewy Inc
16679L109
1010.00000000
NS
USD
39864.70000000
1.683959090312
Long
EC
CORP
US
N
1
N
N
N
Stevanato Group SpA
81560033F7E1CD477507
Stevanato Group SpA
000000000
2691.00000000
NS
USD
87134.58000000
3.680726760055
Long
EC
CORP
IT
N
1
N
N
N
West Pharmaceutical Services Inc
5493007NKRGM1RJQ1P16
West Pharmaceutical Services Inc
955306105
143.00000000
NS
USD
54693.21000000
2.310342938938
Long
EC
CORP
US
N
1
N
N
N
Eli Lilly & Co
FRDRIPF3EKNDJ2CQJL29
Eli Lilly & Co
532457108
294.00000000
NS
USD
137880.12000000
5.824312774143
Long
EC
CORP
US
N
1
N
N
N
4D Molecular Therapeutics Inc
N/A
4D Molecular Therapeutics Inc
35104E100
1273.00000000
NS
USD
23003.11000000
0.971694160246
Long
EC
CORP
US
N
1
N
N
N
MaxCyte Inc
54930053YHXULRFCU991
MaxCyte Inc
57777K106
8127.00000000
NS
USD
37302.93000000
1.575745159722
Long
EC
CORP
US
N
1
N
N
N
Royalty Pharma PLC
549300FGFN7VOK8BZR03
Royalty Pharma PLC
000000000
1579.00000000
NS
USD
48538.46000000
2.050354848946
Long
EC
CORP
GB
N
1
N
N
N
IDEXX Laboratories Inc
OGMTXK0LUU1HKV2P0J84
IDEXX Laboratories Inc
45168D104
94.00000000
NS
USD
47209.62000000
1.994222175238
Long
EC
CORP
US
N
1
N
N
N
Citigroup Global Markets Inc
MBNUM2BPBDO7JBLYG310
Citigroup Global Markets Inc
000000000
197.99429274
PA
USD
197.99429274
0.008363647264
Long
RA
CORP
US
N
2
Repurchase
Y
5.00000000
2023-07-03
203.06415800
USD
201.86927635
USD
UST
N
N
2023-07-17
MORGAN STANLEY INSTITUTIONAL FUND INC
Francis Smith
Francis Smith
Principal Financial Officer